Ian Clark

Operating Partner at Clarus Ventures LLC

Ian Clark

Ian Clark

Operating Partner at Clarus Ventures LLC

Overview
Career Highlights

Novartis Pharmaceuticals UK Ltd.
Novartis AG
Novartis Pharmaceuticals Canada, Inc.

RelSci Relationships

4390

Number of Boards

24

Birthday

08/1961

Age

59

Contact Data
Trying to get in touch with Ian Clark? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Ian Clark likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Partner at Google Ventures

Relationship likelihood: Strong

Treasurer, Chief Financial & Accounting Officer at Denali Therapeutics, Inc.

Relationship likelihood: Strong

Executive Chairman at Nitrome Biosciences, Inc.

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Avrobio, Inc.

Relationship likelihood: Strong

Senior Adviser at EW Healthcare Partners

Relationship likelihood: Strong

Managing Director at ARCH Venture Partners

Relationship likelihood: Strong

President at Stanford University

Relationship likelihood: Strong

Director at Vestergaard Frandsen SA

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at Guardant Health, Inc.

Relationship likelihood: Strong

Co-Founder & President at Guardant Health, Inc.

Relationship likelihood: Strong

Paths to Ian Clark
Potential Connections via
Relationship Science
You
Ian Clark
Operating Partner at Clarus Ventures LLC
Education
B.S. Biological Sciences

The University of Southampton is a public research university located in Southampton, England. They are a research-intensive university and a founding member of the Russell Group. Their successes are acknowledged in international and UK league table rankings and education awards. Their degrees and courses enable you to develop critical thinking and independent learning skills that are essential for future leaders and decision makers. Their lecturers are leaders in their fields and offer you the chance to learn about world-changing research as it happens.

Memberships
Member
Current

TechNet was founded in 1997 by high-tech’s leading CEOs to create a network of the nation’s strongest voices in the industry to unite with both federal and state leaders in helping to shape the public policies that impact the technology industries. TechNet continues to actively promote policies that strengthen the nation’s innovation-driven global competitiveness as well as create private sector initiatives that will ensure U.S. competitiveness and economic leadership. TechNet’s mission is to serve as the voice and advocate of the innovation economy by uniting CEOs and Senior Executives with leading policy makers in a bipartisan effort to sustain and advance America’s global leadership in technology and innovation.

Career History
Operating Partner
2017 - Current

Clarus Ventures focuses on investments in the life science industry. The firm's invests primarily in biopharmaceutical and medical technology companies. Clarus Ventures has particular expertise in research and development, commercialization, business development and operations management at the global level. The firm also makes investment in public company.

Advisor
Current

The University of Southampton is a public research university located in Southampton, England. They are a research-intensive university and a founding member of the Russell Group. Their successes are acknowledged in international and UK league table rankings and education awards. Their degrees and courses enable you to develop critical thinking and independent learning skills that are essential for future leaders and decision makers. Their lecturers are leaders in their fields and offer you the chance to learn about world-changing research as it happens.

Senior Advisor
2018 - ?

The Blackstone Group, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Private Equity, Real Estate, Hedge Fund Solutions and Credit. The Private Equity segment consists of flagship corporate private equity funds, Blackstone Capital Partners funds, sector-focused corporate private equity funds, including energy-focused funds, Blackstone Energy Partners funds, and core private equity fund, Blackstone Core Equity Partners. The Real Estate segment includes management of core real estate fund and non-exchange traded restate investment trusts. The Hedge Fund Solutions segment comprises of Blackstone Alternative Asset Management, which manages hedge funds and includes Indian-focused and Asian-focused closed-end mutual funds. The Credit segment includes GSO Capital Partners LP, which manages credit-oriented funds. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Boards & Committees
Member, Board of Directors
2014 - Prior

InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA.

Non-Executive Director
2007 - Prior

Vernalis Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market; Moxatag, a once-a-day formulation of the antibiotic and amoxicillin; and frovatriptan, used for the acute treatment of migraine. Vernalis also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom.

Director
2009 - Prior

The Bioindustry Association is a nonprofit company headquartered in London, UK. The firm operates as a association to encourage and promote bioscience sector. It was founded by Cormac G. Kilty and Simon Geoffrey Best. Steve Bates is the current CEO, occupying that position since 2012.

Member, Executive Council
Prior

TechNet was founded in 1997 by high-tech’s leading CEOs to create a network of the nation’s strongest voices in the industry to unite with both federal and state leaders in helping to shape the public policies that impact the technology industries. TechNet continues to actively promote policies that strengthen the nation’s innovation-driven global competitiveness as well as create private sector initiatives that will ensure U.S. competitiveness and economic leadership. TechNet’s mission is to serve as the voice and advocate of the innovation economy by uniting CEOs and Senior Executives with leading policy makers in a bipartisan effort to sustain and advance America’s global leadership in technology and innovation.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ian Clark. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ian Clark's profile does not indicate a business or promotional relationship of any kind between RelSci and Ian Clark.